Multiparametric Renal Magnetic Resonance Imaging for Prediction and Annual Monitoring of the Progression of Chronic Kidney Disease over Two Years

被引:0
|
作者
Buchanan, Charlotte E. [1 ]
Mahmoud, Huda [2 ,3 ]
Cox, Eleanor F. [1 ,4 ,5 ]
Prestwich, Benjamin L. [1 ]
Noble, Rebecca A. [2 ]
Selby, Nicholas M. [2 ]
Taal, Maarten W. [2 ]
Francis, Susan T. [1 ,4 ,5 ]
机构
[1] Univ Nottingham, Sir Peter Mansfield Imaging Ctr, Sch Phys & Astron, Nottingham NG7 2RD, England
[2] Univ Nottingham, Ctr Kidney Res & Innovat, Royal Derby Hosp Campus, Derby DE2 3DT, England
[3] Manor Hosp, Walsall Healthcare NHS Trust, Moat Rd, Walsall WS2 9PS, England
[4] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Nottingham NG7 2QW, England
[5] Univ Nottingham, Nottingham NG7 2QW, England
基金
英国医学研究理事会;
关键词
chronic kidney disease; magnetic resonance imaging; multiparametric; progression; monitoring; INTRARENAL OXYGENATION; GFR DECLINE; END-POINT; FIBROSIS; PATHOLOGY; EQUATION; CKD;
D O I
10.3390/jcm12237282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiparametric renal Magnetic Resonance Imaging (MRI) provides a non-invasive method to assess kidney structure and function, but longitudinal studies are limited. Methods: A total of 22 patients with CKD category G3-4 (estimated glomerular filtration rate (eGFR) 15-59 mL/min/1.73 m(2)) were recruited. Annual 3T multiparametric renal MRI scans were performed, comprising total kidney volume (TKV), longitudinal relaxation time (T-1), apparent diffusion coefficient (ADC), Arterial Spin Labelling, and Blood Oxygen Level Dependent relaxation time (T-2*), with 15 patients completing a Year 2 scan. CKD progression over 2 years was defined as eGFR_slope >= -5 mL/min/1.73 m(2)/year. Results: At baseline, T-1 was higher (cortex p = 0.05, medulla p = 0.03) and cortex perfusion lower (p = 0.015) in participants with subsequent progression versus stable eGFR. A significant decrease in TKV and ADC and an increase in cortex T-1 occurred in progressors at Year 1 and Year 2, with a significant decrease in perfusion in progressors only at Year 2. The only decline in the stable group was a reduction in TKV. There was no significant change in cortex or medulla T-2* at Year 1 or Year 2 for progressors or stable participants. Conclusion: Lower renal cortex perfusion and higher T-1 in the cortex and medulla may predict CKD progression, while renal cortex T-1, TKV, and ADC may be useful to monitor progression. This study provides pilot data for future large-scale studies.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Quantitative magnetic resonance imaging of chronic kidney disease: an experimental in vivo study using rat chronic kidney disease models
    Kim, Sang Youn
    Kim, Hyeonjin
    Lee, Joongyub
    Jung, Sung Il
    Moon, Min Hoan
    Joo, Kwon Wook
    Cho, Jeong Yeon
    ACTA RADIOLOGICA, 2023, 64 (01) : 404 - 414
  • [42] Multiparametric magnetic resonance imaging of experimental chronic kidney disease: A quantitative correlation study with histology (vol 13, e0200259, 2018)
    Schley, Gunnar
    Jordan, Jutta
    Ellmann, Stephan
    Rosen, Seymour
    Eckardt, Kai-Uwe
    Uder, Michael
    Willam, Carsten
    Bauerle, Tobias
    PLOS ONE, 2019, 14 (06):
  • [43] Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes
    Raynauld, JP
    Martel-Pelletier, J
    Berthiaume, MJ
    Labonté, F
    Beaudoin, G
    de Guise, JA
    Bloch, DA
    Choquette, D
    Haraoui, B
    Altman, RD
    Hochberg, MC
    Meyer, JM
    Cline, GA
    Pelletier, JP
    ARTHRITIS AND RHEUMATISM, 2004, 50 (02): : 476 - 487
  • [44] Incidental findings in a renal magnetic resonance imaging study for evaluation of chronic kidney disease in type 2 diabetes population
    Makvandi, Kianoush
    Hockings, Paul
    Hulthe, Johannes
    Baid-Agrawal, Seema
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [45] Non-Contrast Renal Magnetic Resonance Imaging to Assess Perfusion and Corticomedullary Differentiation in Health and Chronic Kidney Disease
    Gillis, Keith A.
    McComb, Christie
    Patel, Rajan K.
    Stevens, Kathryn K.
    Schneider, Markus P.
    Radjenovic, Aleksandra
    Morris, Scott T. W.
    Roditi, Giles H.
    Delles, Christian
    Mark, Patrick B.
    NEPHRON, 2016, 133 (03) : 183 - 192
  • [46] Diffusion Weighted Magnetic Resonance Imaging in the Assessment of Renal Function and Parenchymal Changes in Chronic Kidney Disease: A Preliminary Study
    Sulkowska, Katarzyna
    Palczewski, Piotr
    Furmanczyk-Zawiska, Agnieszka
    Perkowska-Ptasinska, Agnieszka
    Wojcik, Damian
    Szeszkowski, Wojciech
    Durlik, Magdalena
    Golebiowski, Marek
    Malkowski, Piotr
    ANNALS OF TRANSPLANTATION, 2020, 25
  • [47] Incidental findings in a renal magnetic resonance imaging study for evaluation of chronic kidney disease in type 2 diabetes population
    Makvandi, Kianoush
    Hockings, Paul
    Hulthe, Johannes
    Baid-Agrawal, Seema
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2759 - I2759
  • [48] Evaluation of Renal Blood Flow in Chronic Kidney Disease Using Arterial Spin Labeling Perfusion Magnetic Resonance Imaging
    Li, Lu-Ping
    Tan, Huan
    Thacker, Jon M.
    Li, Wei
    Zhou, Ying
    Kohn, Orly
    Sprague, Stuart M.
    Prasad, Pottumarthi V.
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (01): : 36 - 43
  • [49] Multiparametric magnetic resonance imaging allows non-invasive functional and structural evaluation of diabetic kidney disease
    Makvandi, Kianoush
    Hockings, Paul D.
    Jensen, Gert
    Unnerstall, Tim
    Leonhardt, Henrik
    Jarl, Lisa, V
    Englund, Camilla
    Francis, Susan
    Sundgren, Anna K.
    Hulthe, Johannes
    Baid-Agrawal, Seema
    CLINICAL KIDNEY JOURNAL, 2022, 15 (07) : 1387 - 1402
  • [50] Reduced oxygenation but not fibrosis defined by functional magnetic resonance imaging predicts the long-term progression of chronic kidney disease
    Sugiyama, Kei
    Inoue, Tsutomu
    Kozawa, Eito
    Ishikawa, Masahiro
    Shimada, Akira
    Kobayashi, Naoki
    Tanaka, Junji
    Okada, Hirokazu
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (06) : 964 - 970